A Trial of Multi-convergent Therapy for Functional Symptoms and Stress in Patients With Inflammatory Bowel Disease
A Randomised Controlled Trial of Multi-convergent Therapy for Inflammatory Bowel Disease Patients With Functional Abdominal Symptoms and High Perceived Stress
1 other identifier
interventional
66
1 country
1
Brief Summary
The purpose of this study is to determine whether multi-convergent therapy is helpful to patients with inflammatory bowel disease who have functional abdominal symptoms or high perceived levels of psychological stress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 26, 2011
CompletedFirst Posted
Study publicly available on registry
August 31, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedJanuary 30, 2020
August 1, 2013
2.3 years
August 26, 2011
January 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Quality of Life in Inflammatory Bowel Disease Questionnaire
Assessed at baseline and at 4 months, 8 months, and 1 year
Secondary Outcomes (6)
Change in Irritable Bowel Syndrome Symptom Severity Score
Assessed at baseline and at 4 months, 8 months, and 1 year
Change in Levenstein Perceived Stress Score
2 monthly intervals over 1 year
Change in Hospital Anxiety and Depression Score
2 monthly intervals over 1 year
Abdominal Symptoms Global Improvement Score
4 monthly intervals over 1 year
Relapse rate in inflammatory bowel disease
1 year
- +1 more secondary outcomes
Study Arms (2)
Course of Multi-Convergent Thearpy
ACTIVE COMPARATORWaiting List for Multi-Convergent Therapy
NO INTERVENTIONInterventions
Cognitive Behavioural Therapy Relaxation Techniques Meditation Stress Management
Eligibility Criteria
You may qualify if:
- Diagnosis of Inflammatory Bowel Disease
- Clinical Remission of inflammatory bowel disease as defined by an adapted disease activity index and a CRP \<10
- Age 18 to 65 years
- Evidence of irritable bowel syndrome (Rome III criteria) or high perceived stress level (Levenstein perceived stress score \> 0.44)
You may not qualify if:
- Use of steroids within 1 month of entry to study
- Initiation or change in dose of medication within 1 month of entry to the study
- Presence of ileostomy or colostomy
- Diagnosis of dementia or cognitive impairment
- Current psychosis or substance misuse
- Change in psychotropic medication in 3 months prior to entry to study
- Previous psychological interventions
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiff and Vale University Health Board
Cardiff, South Glamorgan, CF64 2XX, United Kingdom
Related Publications (2)
Tiles-Sar N, Neuser J, de Sordi D, Baltes A, Preiss JC, Moser G, Timmer A. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2025 Apr 17;4(4):CD006913. doi: 10.1002/14651858.CD006913.pub3.
PMID: 40243391DERIVEDBerrill JW, Sadlier M, Hood K, Green JT. Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. J Crohns Colitis. 2014 Sep;8(9):945-55. doi: 10.1016/j.crohns.2014.01.018. Epub 2014 Feb 13.
PMID: 24529603DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2011
First Posted
August 31, 2011
Study Start
January 1, 2011
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
January 30, 2020
Record last verified: 2013-08